Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
OrbusNeich Medical Group Holdings's 3-Year ROIIC % for the quarter that ended in Dec. 2025 was 12.40%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
FRA:Q8T's 3-Year ROIIC % is ranked better than 63.48% of 794
companies
in the Medical Devices & Instruments industry
Industry Median: 1.52
vs FRA:Q8T: 12.40
OrbusNeich Medical Group Holdings (FRA:Q8T) 3-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
OrbusNeich Medical Group Holdings 3-Year ROIIC % Related Terms
OrbusNeich Medical Group Holdings 3-Year ROIIC % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OrbusNeich Medical Group Holdings 3-Year ROIIC % Chart
FRA:Q8T vs ISRG, BDX, MDLN: 3-Year ROIIC % Comparison
For the Medical Instruments & Supplies subindustry, OrbusNeich Medical Group Holdings's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
OrbusNeich Medical Group Holdings 3-Year ROIIC % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, OrbusNeich Medical Group Holdings's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where OrbusNeich Medical Group Holdings's 3-Year ROIIC % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
OrbusNeich Medical Group Holdings (FRA:Q8T) has a 3-Year ROIIC % of 12.40 as of Dec. 2025. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on OrbusNeich Medical Group Holdings and its competitors. This is 62% below median its historical median of 33.02. Over the past decade, OrbusNeich Medical Group Holdings' 3-Year ROIIC % has ranged from 12.40 to 50.73. According to the industry distribution chart, OrbusNeich Medical Group Holdings ranks #290 out of 794 companies in the Medical Devices & Instruments industry, placing it in the top 36.5%.
Is OrbusNeich Medical Group Holdings' 3-Year ROIIC % too high?
OrbusNeich Medical Group Holdings' current 3-Year ROIIC % of 12.40 is 62% below median its 10-year median of 33.02. Over the past 10 years, this metric has ranged from a low of 12.40 to a high of 50.73. The Medical Devices & Instruments industry median 3-Year ROIIC % is 1.52. OrbusNeich Medical Group Holdings' value of 12.40 is 715.8% above this industry median. Based on the distribution chart, OrbusNeich Medical Group Holdings ranks #290 out of 794 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, OrbusNeich Medical Group Holdings has a GF Score™ of 95/100, reflecting its overall financial health beyond just this single metric.
How does OrbusNeich Medical Group Holdings' 3-Year ROIIC % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, OrbusNeich Medical Group Holdings ranks #290 out of 794 companies for 3-Year ROIIC %. This puts OrbusNeich Medical Group Holdings in the upper half of its industry. The industry median 3-Year ROIIC % is 1.52. OrbusNeich Medical Group Holdings' value of 12.40 is 715.8% above this benchmark. Historically, OrbusNeich Medical Group Holdings' own 3-Year ROIIC % has ranged from 12.40 to 50.73 over the past decade. While the company's 10-year median is 33.02 vs. the industry median of 1.52, OrbusNeich Medical Group Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Medical Devices & Instruments company?
The median 3-Year ROIIC % among Medical Devices & Instruments companies is 1.52, based on 794 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. OrbusNeich Medical Group Holdings's current 3-Year ROIIC % of 12.40 is 715.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on OrbusNeich Medical Group Holdings and its competitors. For the Medical Devices & Instruments industry, the median 3-Year ROIIC % is 1.52 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. OrbusNeich Medical Group Holdings's current 3-Year ROIIC % is 12.40, which is 62% below median its own 10-year median of 33.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OrbusNeich Medical Group Holdings stock overvalued right now?
OrbusNeich Medical Group Holdings (FRA:Q8T) has a current 3-Year ROIIC % of 12.40. The stock's GF Value™ is €0.49, compared to a current price of €0.35 — trading 29% below its estimated fair value. The current 3-Year ROIIC % is 12.40, which is 62% below median its 10-year median of 33.02 and 715.8% above the Medical Devices & Instruments industry median of 1.52. OrbusNeich Medical Group Holdings' overall GF Score™ is 95/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For OrbusNeich Medical Group Holdings (FRA:Q8T), the current 3-Year ROIIC % is 12.40 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is OrbusNeich Medical Group Holdings (FRA:Q8T) Overvalued in 2026?
Based on GuruFocus' analysis, OrbusNeich Medical Group Holdings stock appears to be undervalued.
The current stock price of €0.35 is trading 29% below its estimated GF Value™ of €0.49.
Key valuation signals for FRA:Q8T:
3-Year ROIIC %: 12.40 (62% below median its 10-year median of 33.02)
GF Value™: €0.49 vs. price of €0.35 (29% below fair value)
Industry Position: 715.8% above the Medical Devices & Instruments median (#290 of 794)
No single metric tells the full story. See the FRA:Q8T stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
OrbusNeich Medical Group Holdings Business Description
OrbusNeich Medical Group Holdings Ltd is an investment holding company. The Company principally engaged in the manufacturing, trading, sales and marketing of medical devices/instruments used for the treatment of coronary and peripheral vascular diseases. The group has only one operating segment. The company has presence in APAC, EMEA, Japan, United States, The PRC, and Others of which majority of revenue comes from APAC.
95GF Score
Get the complete analysis for FRA:Q8T
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:Q8T has been successfully added to your 
